What is the clinical evidence available with Octaplasma® in various clinical settings?
December 6, 2024
|By WP Admin
A: Six clinical studies with Octaplasma® have been conducted by Octapharma. In total, 229 patients have been enrolled, and the patients were exposed to a total number of about 1,200 treatment courses with Octaplasma®.3 These studies were conducted in various types of clinical settings including intensive care patients with DIC, hereditary or acquired isolated or combined coagulation factor deficiency, patients undergoing open heart surgeries and extracorporeal surgery, patients suffering from coagulopathy due to liver disease, liver toxicity ,Thrombotic Thrombocytopenic Purpura (TTP), sepsis among others and covered a wide range of patients aged from 0 to 96 years. In all these studies, Octaplasma® has been demonstrated to be safe and effective.3
